Last week, Pfizer reported that a trio of lab experiments suggest that its COVID-19 pill, Paxlovid, will hold up well against the Omicron variant. The antiviral was authorized in December for people at high risk of becoming seriously ill from ...
Read More »
On Monday evening, the Food and Drug Administration announced that it would limit the use of two monoclonal antibody COVID-19 treatments, made by pharmaceutical companies Regeneron and Eli Lilly. Those treatments had been successful at keeping symptomatic patients out of ...
Read More »
Yaspan Tech, Computers, Gadgets, Reviews, News and Analysis